10-K Decoder · All companies

Lyell Immunopharma, Inc.

LYEL · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$40K$60K−33.3%
Operating income−$269M−$359M+24.9%
Net income−$274M−$343M+20.0%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$48.3M−$37.3M−29.5%
Net income−$45.5M−$38.8M−17.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Lyell Immunopharma's revenue in FY2025?
$40K in FY2025 (Fiscal year ended Dec 31, 2025), −33.3% vs $60K a year earlier, per its 10-K filed Mar 2026.
Was Lyell Immunopharma profitable in FY2025?
No: net income was −$274M and operating income −$269M in FY2025.
What was Lyell Immunopharma's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 4, 2026.